Weight loss study for Chinese adults with excess weight
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational medication, orforglipron, taken as a pill to help people with excess weight lose weight. It may be an option for people who have not been able to lose weight with diet alone and who also have weight-related health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult living in China.
- Your body mass index (BMI) is 24 or higher, and if it is between 24 and 28, you must also have at least one weight-related health problem like high blood pressure, high cholesterol, sleep apnea, fatty liver, or heart disease.
- You have tried to lose weight through diet in the past but have not been successful.
- You do not have diabetes (type 1 or type 2) or any other type of diabetes.
- Your weight has not changed by more than 5 kilograms (about 11 pounds) in the 90 days before the study starts.
- You have no history of pancreatitis (inflammation of the pancreas).
- You or a close family member (parent, sibling, or child) have not had a rare thyroid cancer called medullary thyroid carcinoma, and you do not have a condition called MEN2 syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a once-daily pill (orforglipron) to help adolescents with obesity or overweight plus related health problems lose weight. It offers a new option for teens who have struggled to lose weight with diet and exercise alone.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.